Byrsonima crassifolia

Byrsonima crassifolia is an Amazonian fruit tree whose leaf and seed extracts contain phenolic compounds that may influence neurotransmitter systems and glucose metabolism. Research suggests potential antidepressant-like effects and blood sugar regulation properties, though evidence remains preliminary.

Origin & History

Byrsonima crassifolia, commonly known as murici, is a tropical tree in the Malpighiaceae family native to Mexico, Central America, and South America. The plant's leaves, roots, stems, seeds, and fruits are processed into extracts using solvents like methanol, ethyl acetate, or hexane via maceration or fractionation methods.

Historical & Cultural Context

In Mexican traditional medicine with prehispanic origins, Byrsonima crassifolia has been used for mental disorders, diabetes, rheumatism, wound healing, and infections. Roots and stems have been employed since ancient times in Mexico, Central, and South America for antibacterial activity against pathogens like Staphylococcus aureus.

Health Benefits

• May support mood and mental well-being - mouse studies showed antidepressant-like effects with leaf extract (500 mg/kg) in forced swimming tests (preliminary evidence)
• May help regulate blood sugar - diabetic rat studies demonstrated reduced serum glucose and increased insulin release with seed extract (200-400 mg/kg) (preliminary evidence)
• May reduce inflammation - birsonimadiol from seeds suppressed inflammatory markers (NO, PGE2, COX-2, TNF-α, IL-6) in cell and mouse studies (preliminary evidence)
• May provide antioxidant support - fruit pulp extracts reduced oxidative stress markers and increased plasma antioxidant capacity in rat studies (preliminary evidence)
• May offer pain relief - hydroalcoholic extracts showed analgesic and sedative effects in animal models (preliminary evidence)

How It Works

Byrsonima crassifolia's phenolic compounds appear to modulate neurotransmitter pathways, potentially affecting serotonin and dopamine systems to produce antidepressant-like effects. The seed extract may enhance pancreatic beta-cell insulin release while improving glucose uptake in peripheral tissues. These mechanisms likely involve antioxidant activity and direct interaction with metabolic enzymes.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Byrsonima crassifolia. All available evidence comes from preclinical animal models including mouse forced swimming tests showing antidepressant effects (PMID: 21788126), diabetic rat studies demonstrating glucose reduction (PMID: 25435601), and anti-inflammatory research in cell cultures and mice (PMID: 30263306).

Clinical Summary

Current research is limited to animal studies with no human clinical trials available. Mouse studies using 500 mg/kg of leaf extract showed antidepressant-like behavior in forced swimming tests. Diabetic rat studies demonstrated significant reductions in serum glucose levels and increased insulin release with seed extract treatment. The evidence remains preliminary and requires human validation studies to confirm therapeutic potential.

Nutritional Profile

Byrsonima crassifolia (Nance/Murici) fruit contains approximately 70-80% water content. Macronutrients per 100g fresh fruit: carbohydrates ~14-18g (primarily simple sugars glucose and fructose), dietary fiber ~2-4g (pectin-rich), protein ~0.5-1.2g, fat ~0.3-0.8g. Micronutrients: vitamin C ~30-80mg/100g (notable but lower than acerola), vitamin A precursors (beta-carotene ~0.1-0.3mg/100g), potassium ~120-180mg/100g, calcium ~15-25mg/100g, magnesium ~10-18mg/100g, phosphorus ~12-20mg/100g, iron ~0.3-0.8mg/100g. Key bioactive compounds: flavonoids including quercetin and kaempferol derivatives concentrated in leaves and bark; triterpenoids including birsonimadiol (a lupane-type triterpene isolated from seeds, primary anti-inflammatory compound); phenolic acids including gallic acid and ellagic acid in bark and leaves; tannins (condensed and hydrolyzable) ~2-5% in bark; anthocyanins in fruit skin contributing to yellow-orange pigmentation. Seed extracts contain active hypoglycemic constituents including saponins and flavonoid glycosides. Leaf extracts contain alkaloids and terpenoids associated with observed antidepressant-like activity. Bioavailability notes: polyphenol absorption likely enhanced by the fruit's natural fat content; birsonimadiol bioavailability not formally characterized in humans; most bioactive compound data derives from organic solvent extractions used in preclinical studies, meaning real-world oral bioavailability from whole food consumption remains poorly characterized.

Preparation & Dosage

Based on animal studies only: Methanolic leaf extract 500 mg/kg (standardized to flavonoids) for mood support; hexane seed extract 200-400 mg/kg for blood sugar regulation. No human dosage data available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Rutin, Green Tea Extract, Alpha-lipoic acid, Cinnamon

Safety & Interactions

Safety data for Byrsonima crassifolia supplements is extremely limited due to lack of human studies. Potential interactions with diabetes medications could cause hypoglycemia due to glucose-lowering effects observed in animal studies. Concurrent use with antidepressants may theoretically amplify mood-related effects. Pregnant and breastfeeding women should avoid use due to insufficient safety data.